| Celtic Therapeutics sets up $50 million Swiss ADC company - The Pharma Letter |
|
|
Keywords: Celtic Thera, ADC Thera, Spirogen, Multiple cancer indications, Antibody-drug-conjugates, Swiss company Article | 26 March 2012 USA-based private equity firm Celtic Therapeutics Management has announced a significant commitment to antibody-drug-conjugate (ADC) products, with the launch of ... Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe. |